63459-0348-04 — Bendamustine Hcl 100 Mg/4ml IV Soln (bendeka) *teva Equiv*
Cite this view
HANK Price Transparency. (n.d.). BENDAMUSTINE HCL 100 MG/4ML IV SOLN (BENDEKA) *TEVA EQUIV* (NDC 63459-0348-04) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/63459-0348-04?code_type=NDC
“BENDAMUSTINE HCL 100 MG/4ML IV SOLN (BENDEKA) *TEVA EQUIV* (NDC 63459-0348-04) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/63459-0348-04?code_type=NDC. Accessed .
“BENDAMUSTINE HCL 100 MG/4ML IV SOLN (BENDEKA) *TEVA EQUIV* (NDC 63459-0348-04) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/63459-0348-04?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $7,165–$8,128 (25th–75th percentile) across 2 hospitals · 1 payer.
“Negotiated” is the hospital’s negotiated facility rate for this NDC 63459-0348-04 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| ADVENTIST HEALTHCARE WHITE OAK MEDICAL CENTER Both | All Payers | All Plans | $6,684.31 | $6,684.31 | $6,550.62 | 2025-12-31 | MRF ↗ |
| ADVENTIST HEALTHCARE SHADY GROVE MEDICAL CENTER Both | All Payers | All Plans | $8,608.82 | $8,608.82 | $8,436.64 | 2025-12-31 | MRF ↗ |